While Pfizer does not currently make readily available GLP-1s such as Ozempic or Wegovy, they are attempting to develop their own GLP-1s, so may benefit from greater demand for these drugs
When a person does desire to stop the medication, it is ideal if they can wean off of it, rather than stop abruptly
Environmental and Sustainability Considerations GLP-1 manufacturing expansion also raises sustainability issues
10.1016/j.jtherbio.2019.03.009 155 SunF.PalmerK.HandelM
(2022) Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation Biomedicines, 2022 Oct 25;10(11):2696